indicators

2 trials

Sponsors

The First Affiliated Hospital of university of Science and Technology of China, Taizhou Tumor Hospital

Conditions

Malignant tumorNovel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19)

Active, not recruitingChiCTR2000032460

The First Affiliated Hospital of university of Science and Technology of ChinaNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-01-20Updated: 2020-05-04

Unknown Phase

Feasibility study of a nutritional screening model based on NRS2002 combined with inflammatory, biochemical, and immune indicators to predict adverse events in patients with malignant tumors after radiotherapy and/or chemotherapy

RecruitingChiCTR2000033571

Taizhou Tumor HospitalMalignant tumor

Start: 2020-06-01Updated: 2020-06-08